Table 2

Procedural and Outcome Data

Patient #Age, yrsSexEFTarget VesselLesions Treated (n)Duration of Support (h)Pump Flow During PCI (l/min)Angiographic SuccessMACE at 30 DaysSecondary End Points
164F25ULM31.52.2YMI
280M35LPC32.42.3Y
380M20ULM22.12.0Y
473M26LPC32.52.1YDeath (day 14)
569M28LPC10.72.1Y
664M20ULM10.72.1Y
781M18ULM21.82.0Y
846F30ULM22.32.3Y
936M32ULM31.92.3Y
1077M29ULM41.12.4YHemolysis
1166M30LPC20.42.4Y
1259F32ULM31.32.5YTransfusion
1367M27LPC22.11.9YMI
1447M24LPC32.12.2YVT
1568M15LPC22.02.4Y
1677M35ULM42.12.4Y
1770M30ULM12.32.6YDeath (day 12)Hemolysis, renal failure, transfusion, VT
1857M34ULM31.72.3Y
1963M16ULM31.62.1Y
2079M24ULM31.51.5Y

— = not applicable; EF = ejection fraction; LPC = last patent conduit; MACE = major adverse cardiac events; MI = myocardial infarction; PCI = percutaneous coronary intervention; Pt = patient; ULM = unprotected left main; VT = ventricular tachycardia; other abbreviations as in Table 1.